- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bal Pharma's board deferred the merger proposal with subsidiary Lifezen Healthcare due to inadequate data. Management is tasked with re-presenting the proposal with full details for future consideration, ensuring an informed decision.